Log in
Enquire now
‌

Umlaut.bio

Umlaut.bio is a developer of tRNA-modifying small molecules founded in 2024 by Bastian Linder.

OverviewStructured DataIssuesContributors

Contents

umlaut.bio
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biotechnology
Biotechnology
Health technology
Health technology
CEO
‌
Karsten Fischer
Founder
‌
Bastian Linder
‌
Karsten Fischer
Number of Employees (Ranges)
1 – 10
Email Address
info@umlaut.bio
Investors
BaseLaunch
BaseLaunch
Founded Date
2024
Total Funding Amount (USD)
3,500,000
Latest Funding Round Date
February 20, 2026
Latest Funding Type
Pre-Seed
Pre-Seed
Country
Switzerland
Switzerland
Headquarters
Zürich
Zürich

Other attributes

Latest Funding Round Amount (USD)
3,500,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Umlaut.bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.